JP2014169285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014169285A5 JP2014169285A5 JP2014019893A JP2014019893A JP2014169285A5 JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5 JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5
- Authority
- JP
- Japan
- Prior art keywords
- production example
- dimethyl
- iodophenyl
- trifluoromethyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014019893A JP5799117B2 (ja) | 2013-02-05 | 2014-02-05 | ウラシル誘導体からなる医薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013020426 | 2013-02-05 | ||
| JP2013020426 | 2013-02-05 | ||
| JP2014019893A JP5799117B2 (ja) | 2013-02-05 | 2014-02-05 | ウラシル誘導体からなる医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014169285A JP2014169285A (ja) | 2014-09-18 |
| JP2014169285A5 true JP2014169285A5 (cg-RX-API-DMAC7.html) | 2015-04-30 |
| JP5799117B2 JP5799117B2 (ja) | 2015-10-21 |
Family
ID=51691962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014019893A Expired - Fee Related JP5799117B2 (ja) | 2013-02-05 | 2014-02-05 | ウラシル誘導体からなる医薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5799117B2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6990663B2 (ja) * | 2016-05-31 | 2022-01-13 | シエッシ ファーマスーティシ エス.ピー.エー. | ヒト好中球エラスターゼ阻害剤としてのイミダゾロン化合物 |
| CA3026983A1 (en) * | 2016-06-08 | 2017-12-14 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds |
| EP3787612A4 (en) | 2018-05-04 | 2021-11-17 | Remedy Plan, Inc. | CANCER TREATMENTS AGAINST CANCER STEM CELLS |
| PH12022551081A1 (en) | 2019-11-06 | 2024-06-19 | Remedy Plan Inc | Cancer treatments targeting cancer stem cells |
| GB201918414D0 (en) | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency |
| ES2970315T3 (es) * | 2020-07-31 | 2024-05-28 | Abarceo Pharma Ab | Nuevos inhibidores del VDAC1 |
| WO2023033097A1 (ja) * | 2021-09-02 | 2023-03-09 | Eaファーマ株式会社 | 複素環スルホンアミド誘導体の製造方法、およびその合成中間体 |
| CN113952359A (zh) * | 2021-11-19 | 2022-01-21 | 大连理工大学盘锦产业技术研究院 | 顺铂与Tri-1的联合抗肺癌药物组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
| JP5709999B2 (ja) * | 2011-08-01 | 2015-04-30 | 大日本住友製薬株式会社 | ウラシル誘導体およびその医薬用途 |
-
2014
- 2014-02-05 JP JP2014019893A patent/JP5799117B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10501465B2 (en) | Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors | |
| DE602004010206T2 (de) | Dipeptidyl Peptidase Inhibitoren. | |
| RU2682672C2 (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| AU2020407200A1 (en) | Irak degraders and uses thereof | |
| JP5869338B2 (ja) | タンパク質キナーゼ阻害剤 | |
| JP5366968B2 (ja) | Dna中のg−四重鎖領域と相互作用するナフタレンジイミド化合物 | |
| US8084466B2 (en) | Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor | |
| CY1111651T1 (el) | Παραγωγα 3-(ετεροαρυλ-oξυ)-2-αλκυλ-1-αζα- δικυκλοαλκυλιου ως συνδετες του αλφα.7-nachr για τη θεραπεια των ασθενειων του κνς | |
| WO2021158634A1 (en) | Irak degraders and uses thereof | |
| JP2022536092A5 (cg-RX-API-DMAC7.html) | ||
| US9518055B2 (en) | Imidazopyridyl compounds as aldosterone synthase inhibitors | |
| KR20190130129A (ko) | 벤조디아제핀 유도체의 제조 방법 | |
| US20160264567A1 (en) | Substituted sulfonamide compounds | |
| CN103328468A (zh) | 用于治疗疼痛、精神障碍、认知损害或阿尔茨海默病的α-7烟碱型受体调节剂 | |
| TW200634015A (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders | |
| JP2009500329A (ja) | アミノ−5−(6員)ヘテロアリールイミダゾロン化合物およびβ−セレクターゼ調節のためのその使用 | |
| JP2009532424A (ja) | ドーパミンd3受容体のモジュレーターとしてのアザビシクロ[3.1.0]ヘキシル誘導体 | |
| US10875848B2 (en) | Inhibiting fatty acid synthase (FASN) | |
| JP2006519868A5 (cg-RX-API-DMAC7.html) | ||
| JP2018534243A5 (cg-RX-API-DMAC7.html) | ||
| WO2026090477A1 (en) | Helicase inhibitors and uses thereof | |
| US10202401B2 (en) | Process for making tetracyclic heterocycle compounds | |
| EP3134406A1 (en) | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c]pyridine compounds as glyt1 inhibitors | |
| UA88795C2 (ru) | Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений | |
| CN105272921A (zh) | 一种制备Ceritinib的方法及其中间体化合物 |